Supplementary Table S2 from Resistance to Durvalumab and Durvalumab Plus Tremelimumab is Associated with Functional <i>stk11</i> Mutations in Patients with Non–Small Cell Lung Cancer and is Reversed by STAT3 KnockdownNabendu Pore, Song Wu,Nathan Standifer, Maria Jure-Kunkel,Melissa de los Reyes,Yashaswi Shrestha,Rebecca Halpin,Raymond Rothstein,Kathy Mulgrew, Stephen Blackmore,Philip Martin,John Meekin,Matthew Joseph Griffin, Ina Bisha,Theresa A. Proia,Ricardo J. Miragaia,Ronald Herbst,Ashok Gupta,Shaad E. Abdullah,Rajiv Raja,Melanie M. Frigault,J. Carl Barrett,Phillip A. Dennis,Maria Libera Ascierto, Michael Oberstopenalex（2023）引用 0|浏览0暂无评分关键词Tumor Mutational BurdenAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
